Effects of PTK787/ZK222584, a Tyrosine Kinase Inhibitor, on the Growth of a Poorly Differentiated Thyroid Carcinoma: An Animal Study

Endocrinology

Volumn 145, Issue 3, 2004, Pages 1031-1038

  Schoenberger, Johann ^a   Grimm, Daniela ^b   Kossmehl, Peter ^b   Infanger, Manfred ^b   Kurth, Ekkehard ^b   Eilles, Christoph ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE INHIBITOR; RADIOACTIVE IODINE; VASCULOTROPIN; VATALANIB;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CANCER GROWTH; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; DRUG TOLERANCE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMPLANTATION; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RECEPTOR BLOCKING; THYROID CARCINOMA; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA, FOLLICULAR; ANGIOGENESIS INHIBITORS; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PHTHALAZINES; PROTEIN-TYROSINE KINASES; PYRIDINES; THYROGLOBULIN; THYROID NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 1442299164     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1228     Document Type: Article

References (29)

1. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N 1989 Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309
2. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW 1996 Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442
3. Shibuya M, Yamguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M 1990 Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (FLT) closely related to the fms family. Oncogene 5:519-524
4. Terman BI, Dougher VM, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P 1992 Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187:1579-1586
5. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N 1992 Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253
6. Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marme D 1997 Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57:5421-5425
7. Plate KH, Breier G, Millauer B, Ullrich A, Risau W 1993 Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822-5827
8. Lennard CM, Patel A, Wilson J, Reinhardt B, Tuman C, Fenton C, Blair E, Francis GL, Tuttle RM 2001 Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery 129:552-558
9. Baker CH, Solorzano CC, Fidler IJ 2002 Blockade of vascular endothelial growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res 62:1996-2002
10. Drevs J, Muller-Driver R, Wittig C, Fuxius S, Esser N, Hugenschmidt H, Konerding MA, Allegrini PR, Wood J, Hennig J, Unger C, Marme D 2002 PTK787/ZK222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. Cancer Res 62:4015-4022
11. Ellis LM, Takahashi Y, Liu W, Shaheen RM 2000 Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist 5(Suppl 1):11-15
12. Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rosel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F 2000 PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res 60:2178-2189
13. Schönberger J, Bauer J, Spruss T, Weber G, Chahoud I, Eilles C, Grimm D 2000 Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med 78:102-110
14. Junqueira LCU, Cossermelli W, Brentani R 1978 Differential staining of collagens type I, II, III by Sirius red and polarization microscopy. Arch Histol Jpn 41:267-274
15. Rothermund L, Kreutz R, Kossmehl P, Fredersdorf S, Shakibaei M, Schulze-Tanzil G, Paul M, Grimm D 2002 Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy. Am J Hypertens 15:644-652
16. Grimm D, Cameron D, Griese DP, Riegger GAJ, Kromer EP 1998 Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc Res 40:297-306
17. Kossmehl P, Shakibaei M, Cogoli A, Infanger M, Curcio F, Schonberger J, Eilles C, Bauer J, Pickenhahn H, Schulze-Tanzil G, Paul M, Grimm D 2003 Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways. Endocrinology 144: 4172-4179
18. Segal K, Shpitzer T, Feinmesser M, Stern Y, Feinmesser R 1996 Angiogimesis in follicular tumors of the thyroid. J Surg Oncol 63:95-98
19. Bunone G, Vigneri P, Mariani L, Buto S, Collini P, Pilotti S, Pierotti MA, Bongarzone I 1999 Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 155:1967-1976
20. Crew JP, Fuggle S, Bicknell R 2000 Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumor progression. Br J Cancer 82:161-166
21. Gasparini G, Toi M, Grankvist K 1997 Prognostic significance of vascular endothelial growth factor in node-negative breast carcinoma. J Natl Cancer Inst 89:139-147
22. Chen CA, Cheng WF, Lee CN 1999 Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Gynecol Oncol 74:235-240
23. Jacobsen J, Rasmuson T, Grankvist K 2000 Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. J Urol 163:343-347
24. Drevs J, Hofmann I, Hugenschmidt H, Wittig C, Madjar H, Muller M, Wood J, Martiny-Baron G, Unger C, Marme D 2000 Effects of PTK787/ZK222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res 60:4819-4824
25. Satyaswaroop PG, Tabibzadeh SS 1991 Extracellular matrix and the patterns of differentiation of human endometrial carcinomas in vitro and in vivo. Cancer Res 51:5661-5666
26. Deryugina EI, Soroceanu L, Strongin AY 2002 Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 62:580-588
27. Musolino C, Calabro L, Bellomo G, Martello F, Loteta B, Pezzano C, Rizzo V, Alonci A 2002 Soluble angiogenic factors: implications for chronic myeloproliferative disorders. Am J Hematol 69:159-163
28. Raveh E, Cohen M, Shpitzer T, Feinmesser R 1995 Carcinoma of the thyroid: a cause of hypercoagulability? Ear Nose Throat J 74:110-112
29. Thomas A, Morgan B, Decatris A, Henry A, Pfister C, Gano C, Moss D, Laurent D, Dugan M, Steward W 2002 A phase I study of the oral vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor PTK/ZK on a twice daily schedule in patients with advanced cancer. EJC 38(Suppl 7):77 (Abstract)